Ascendis Pharma A/S (ASND)

Ascendis Pharma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	320.24	392.16	444.77	446.27	584.52	598.11
Short-Term Investments	-	7.28	290.69	235.8	134.28	-
Cash & Short-Term Investments	320.24	399.44	735.46	682.06	718.8	598.11
Cash Growth	-45.33%	-45.69%	7.83%	-5.11%	20.18%	115.25%
Receivables	68.69	55.77	25.63	23.19	7.34	5.41
Inventory	232.68	208.93	130.67	75.41	-	-
Prepaid Expenses	42.5	38.58	31.72	25.23	13.99	7.65
Total Current Assets	664.11	702.72	923.47	805.89	740.13	611.17
Property, Plant & Equipment	107.16	110.63	129.1	126.05	108.11	45.07
Long-Term Investments	24.8	5.69	30.42	145.91	124.46	15.54
Goodwill	-	3.5	3.5	3.5	3.5	3.5
Other Intangible Assets	4.3	0.92	1.33	1.78	2.22	-
Other Long-Term Assets	2.13	2.13	1.92	1.81	1.38	1.46
Total Assets	802.5	825.59	1,090	1,085	979.79	676.73
Accounts Payable	94.53	94.57	101.03	59.42	21.9	27.77
Accrued Expenses	22.7	41.18	31.99	29.95	23.38	13.35
Current Portion of Long-Term Debt	424.77	11.23	11.63	-	-	-
Current Portion of Leases	14.62	14.17	13.79	7	6.86	5.9
Current Income Taxes Payable	3.34	2.3	5.49	0.2	0.3	0.12
Current Unearned Revenue	1.18	1.18	-	2.6	0.36	0.86
Other Current Liabilities	237.84	32.72	7.34	1.19	-	-
Total Current Liabilities	798.97	197.34	171.27	100.36	52.8	47.99
Long-Term Debt	146.45	534.25	387.56	-	-	-
Long-Term Leases	83.18	84.62	95.4	97.97	85.12	30.72
Long-Term Unearned Revenue	5	5.95	14.21	2.96	-	-
Long-Term Deferred Tax Liabilities	7.09	5.83	-	-	-	-
Other Long-Term Liabilities	-	143.3	157.95	-	3.16	0.91
Total Liabilities	1,041	971.28	826.39	201.29	141.08	79.62
Common Stock	7.82	7.75	7.68	7.65	7.22	6.44
Additional Paid-In Capital	2,144	2,123	2,113	2,108	1,729	1,122
Retained Earnings	-2,390.88	-2,277.1	-1,860.49	-1,235.51	-1,030.28	-611.32
Treasury Stock	-0.12	-0.15	-0.15	-0.02	-	-
Comprensive Income & Other	0.78	0.72	3.45	3.78	133.03	79.9
Shareholders' Equity	-238.18	-145.7	263.35	883.64	838.71	597.11
Total Liabilities & Equity	802.5	825.59	1,090	1,085	979.79	676.73
Total Debt	669.01	644.27	508.38	104.96	91.98	36.62
Net Cash (Debt)	-348.78	-244.83	234.57	684.66	742.1	561.49
Net Cash Growth	-	-	-65.74%	-7.74%	32.17%	102.07%
Net Cash Per Share	-6.17	-4.35	4.18	12.50	14.66	12.07
Filing Date Shares Outstanding	57.34	56.61	56.04	56.78	53.75	47.99
Total Common Shares Outstanding	57.34	56.61	56.04	56.78	53.75	47.99
Working Capital	-134.86	505.38	752.2	705.53	687.33	563.18
Book Value Per Share	-4.15	-2.57	4.70	15.56	15.60	12.44
Tangible Book Value	-242.48	-150.12	258.52	878.36	832.99	593.62
Tangible Book Value Per Share	-4.23	-2.65	4.61	15.47	15.50	12.37
Machinery	-	38.86	36.15	25.77	19.8	11.98
Leasehold Improvements	-	19.38	20.13	18.07	8.54	4.29

Source: S&P Capital IQ. Standard template.